[1] Huang CC, Kuo KK, Cheng TC, et al. Development of membrane-bound GM-CSF and IL-18 as an effective tumor vaccine[J].PLoS One, 2015, 10(7):1-13.
[2] Liu W, Hu M, Wang Y, et al. Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3β signaling[J]. Oncol Rep, 2015,33(3):1049-1056.
[3] 吕雨虹,陈庆,赵娟,等. 转染白细胞介素18基因通过下调多药耐药基因表达增强顺铂对C6胶质瘤细胞毒作用[J]. 中国现代医学杂志,2016, 26(10):20-24.
[4] 宋杨英,张建军,程天军. IL-18基因转染对大鼠胶质瘤体内生长及肿瘤细胞凋亡的影响[J]. 河北北方学院学报:自然科学版, 2016,42(2):11-15.
[5] 杨升,卢辉山,陈湘琦,等. 白细胞介素-18对Lewis肺癌小鼠移植瘤生长及移植瘤细胞凋亡的作用[J]. 肿瘤防治研究,2009, 28(7):563-565.
[6] 陈湘琦,林挺岩,李志鹰,等. IL-18对Lewis肺癌小鼠移植瘤生长的抑制作用[J]. 现代肿瘤医学,2008,16(9):1458-1459.
[7] 刘炜炜,嵇菲,宋立巍,等. IL-18对人舌癌移植瘤的抑制作用[J]. 吉林医学,2011,32(20):4070-4072.
[8] 李文玲,赵文清,周娜静,等.外源性IL-18基因对C6胶质瘤细胞体内致瘤抑制作用[J].细胞生物学杂志,2008,30(1):95-99.
[9] 杨广民,段秀梅,李首庆,等.联合应用MAGE-1与IL-18基因疫苗体外抗肝癌作用的实验研究[J].中国现代医学,2011,21(31):3872-3875.
[10] 方艳秋,谭岩,段秀梅,等. IL-18在体外培养系统中诱导肿瘤快速杀伤效应及肿瘤特异性CTL[J].免疫学杂志,2004, 20(4):251-255.
[11] Fabbi M, Carbotti G, Ferrini S. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP[J]. J Leukoc Biol,2015,97(4):665-675.
[12] Stegmann KA, De Souza JB, Riley EM. IL-18-induced expression of high-affinity IL-2R on murine NK cells is essential for NK-cell IFN-γ production during murine Plasmodium yoelii infection[J]. Eur J Immunol, 2015,45(12):3431-3440.
[13] 陈吉泉.IL-18及其抗肿瘤作用[J].国外医学:免疫学分册,2000,24(4):239-242.
[14] 崔潋,郝淑维,李新伟,等.IL-18基因转染对小鼠卵巢癌OVHM体外增殖及体内成瘤的影响[J].细胞与分子免疫学杂志,2008, 24(6):577-580.
[15] Alagkiozidis I, Facciabene A, Tsiatas M, et al. Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy[J]. J Transl Med,2011,9(77):1-12.
[16] Shen YP, Lin SI, Chen IH, et al. A HLA-A2-restricted CTL epitope induces anti-tumor effects against human lung cancer in mouse xenograft model[J]. Oncotarget, 2016, 7(1):671-683.
[17] Wang Y, Xu Z, Zhou F, et al. The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors[J]. Exp Hematol Oncol, 2015,4(32):1-12.
[18] Markowitz GJ, Yang P, Fu J, et al. Inflammation-dependent IL18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes[J]. Cancer Res, 2016, 76(8):2394-2405.
[19] 郝明志,林海澜,陈起忠,等.重组人血管内皮抑制素联合肝动脉介入治疗对中晚期肝癌无疾病进展生存期的影响[J]. 临床肝胆病杂志,2016,32(1):92-96. |